Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Your research
Source: nct - Country: Macedonia, the former Yugoslav Republic of,Serbia,South Africa,United Kingdom,Czech Republic,Italy,Spain,France - Phase: terminated
Professor
Update Il y a 5 ans
A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With Hyperphosphatemia
This study consists of a 4 week run-in period with a Ca based phosphate binder and 12 weeks treatment period by MCI-196 or placebo, (both on Ca based phosphate binder). During the treatment period, MCI-196 or placebo will be titrated every 3 weeks.
Country
Czech Republic
,
France
,
Germany
,
Italy
,
Macedonia, the former Yugoslav Republic of
,
Poland
,
Serbia
,
South Africa
,
Spain
,
United Kingdom
,
organs
None
Specialty
None
Closed trial
More information
1